부산대학교 도서관

Lattime E; Israeli R; Petrylak DP; Kaufman H; Plante M; DiPaola RS; Manson K; Schuetz T

Journal of Translational Medicine, Vol 4, Iss 1, p 1 (2006)

Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York City, NY, USA. Electronic address: rosenbj1@mskcc.org.; Mamtani R; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Sonpavde GP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Loriot Y; Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Duran I; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.; Lee JL; Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea.; Matsubara N; National Cancer Center Hospital East, Chiba, Japan.; Vulsteke C; Center for Oncological Research, University of Antwerp, Integrated Cancer Center Ghent, Ghent, Belgium.; Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain.; Sridhar SS; Princess Margaret Cancer Center, Toronto, Canada.; Pappot H; Region Hovedstaden, Hillerød, Denmark.; Gurney H; Macquarie University, Sydney, Australia.; Bedke J; Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany.; van der Heijden MS; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Galli L; Azienda Ospedaliero-Universitaria Pisana Spedali Riuniti S. Chiara, Pisa, Italy.; Keam B; Seoul National University Hospital, Seoul, South Korea.; Masumori N; Sapporo Medical University, Sapporo, Japan.; Meran J; Internal Medicine 2, Krankenhaus der Barmherzigen Brüder Wien, Vienna, Austria.; O'Donnell PH; University of Chicago, Chicago, IL, USA.; Park SH; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.; Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain.; Sengeløv L; Herlev Gentofte Hospital, Herlev, Denmark.; Uemura H; Yokohama City University Medical Center, Yokohama, Japan.; Skaltsa K; IQVIA, Barcelona, Spain.; Campbell M; Seagen, Bothell, WA, USA.; Matsangou M; Astellas Pharma, Northbrook, IL, USA.; Wu C; Astellas Pharma, Northbrook, IL, USA.; Hepp Z; Seagen, Bothell, WA, USA.; McKay C; Astellas Pharma, Northbrook, IL, USA.; Powles T; Barts Cancer Centre, Queen Mary University of London, London, UK.; Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, CT, USA.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA.; Pouessel D; Department of Medical Oncology & Clinical Research Unit, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse (IUCT-Oncopôle), Toulouse, France.; Park CH; Norton Cancer Institute, Louisville, KY.; Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO.; Petrylak DP; Yale School of Medicine, New Haven, CT.; Agarwal N; Huntsman Cancer Institute, Salt Lake City, UT.; Gupta S; Huntsman Cancer Institute, Salt Lake City, UT.; Fléchon A; Centre Léon Bérard, Lyon, France.; Ramamurthy C; University of Texas Health Science Center at San Antonio, San Antonio, TX.; Davis NB; Vanderbilt-Ingram Cancer Center, Nashville, TN.; Recio-Boiles A; University of Arizona Cancer Center, Tucson, AZ.; Sternberg CN; Weill Cornell Medical College of Cornell University, New York, NY.; Bhatia A; Gilead Sciences, Inc, Morris Plains, NJ.; Pichardo C; Gilead Sciences, Inc, Morris Plains, NJ.; Sierecki M; Gilead Sciences, Inc, Morris Plains, NJ.; Tonelli J; Gilead Sciences, Inc, Morris Plains, NJ.; Zhou H; Gilead Sciences, Inc, Morris Plains, NJ.; Tagawa ST; Weill Cornell Medical College of Cornell University, New York, NY.; Loriot Y; Institut de Cancérologie Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; O'Donnell PH; University of Chicago, Chicago, IL.; Hoimes CJ; Duke Cancer Institute, Duke University, Durham, NC.; Petrylak DP; Yale Cancer Center, New Haven, CT.; Flaig TW; University of Colorado Comprehensive Cancer Center, Aurora, CO.; Moon HH; Kaiser Permanente Southern California, Riverside, CA.; Friedlander TW; University of California San Francisco Medical Center, San Francisco, CA.; Mar N; University of California Irvine, Irvine, CA.; McKay RR; University of California San Diego, San Diego, CA.; Srinivas S; Stanford University Medical Center, Stanford, CA.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Ramamurthy C; MD Anderson Cancer Center, University of Texas Health, San Antonio, TX.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO.; Bracarda S; Azienda Ospedaliera Santa Maria Terni, Terni, Italy.; Wright P; Seagen Inc, Bothell, WA.; Hepp Z; Seagen Inc, Bothell, WA.; Carret AS; Seagen Inc, Bothell, WA.; Yu Y; Seagen Inc, Bothell, WA.; Dillon R; Astellas Pharma Inc, Northbrook, IL.; Kataria R; Merck & Co, Inc, Rahway, NJ.; Beaumont JL; Clinical Outcomes Solutions Ltd, Tucson, AZ.; Purnajo I; Clinical Outcomes Solutions Ltd, Tucson, AZ.; Rosenberg JE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Crawford ED; Department of Urology, University of California San Diego, La Jolla, California.; Bryce AH; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona.; Hussain MH; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois.; Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Cooperberg MR; Department of Urology, University of California at San Francisco, San Francisco, California.; Petrylak DP; Yale New Haven Health, New Haven, Connecticut.; Shore N; Carolina Urologic Research Center/Genesis Care, Myrtle Beach, South Carolina.; Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, Ohio.; Tagawa ST; Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, New York.; Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Aparicio AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina.; Boike TP; Michigan Healthcare Professionals, Troy, Michigan.; Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Carducci MA; Hopkins Kimmel Cancer Center, Baltimore, Maryland.; Chapin BF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.; Davis JW; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Dorff T; City of Hope Comprehensive Cancer Center, Duarte, California.; Eggener SE; Departments of Surgery (Urology), University of Chicago Medical Center, Chicago, Illinois.; Feng FY; Departments of Radiation Oncology, Urology, and Medicine, University of California San Francisco, San Francisco, California.; Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Higano C; University of British Columbia, Vancouver, British Columbia, Canada.; Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California.; Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Morris M; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Murray KS; Department of Urology, NYU Langone Health, New York, New York.; Poage W; Prostate Conditions Education Council, Centennial, Colorado.; Rettig MB; Department of Medicine, Division of Hematology-Oncology, VA Greater Los Angeles, Los Angeles, California.; Departments of Medicine and Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Sartor O; Tulane Cancer Center, New Orleans, Louisiana.; Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Sieber P; Keystone Urology Specialists, Lancaster, Pennsylvania.; Small E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, California.; Yu EY; Department of Medicine, Division of Hematology & Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington.; Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, Utah Southwestern Medical Center, Dallas, Texas.; Koo PJ; Banner MD Anderson Cancer Center, Phoenix, Arizona.

Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9918591887306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2771-554X (Electronic) Linking ISSN: 2771554X NLM ISO Abbreviation: JU Open Plus Subsets: PubMed not MEDLINE

Bryce AH; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona.; Crawford ED; Department of Urology, University of California San Diego, La Jolla, California.; Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Hussain MH; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois.; Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Cooperberg MR; Department of Urology, University of California at San Francisco, San Francisco, California.; Petrylak DP; Yale New Haven Health, New Haven, Connecticut.; Shore N; Carolina Urologic Research Center/Genesis Care, Myrtle Beach, South Carolina.; Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, Ohio.; Tagawa ST; Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, New York.; Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Aparicio AM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina.; Boike TP; Michigan Healthcare Professionals, Troy, Michigan.; Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California.; Carducci MA; Hopkins Kimmel Cancer Center, Baltimore, Maryland.; Chapin BF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.; Davis JW; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Dorff T; City of Hope Comprehensive Cancer Center, Duarte, California.; Eggener SE; Departments of Surgery (Urology), University of Chicago Medical Center, Chicago, Illinois.; Feng FY; Departments of Radiation Oncology, Urology, and Medicine, University of California San Francisco, San Francisco, California.; Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Higano C; University of British Columbia, Vancouver, British Columbia, Canada.; Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California.; Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Morris M; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Murray KS; Department of Urology, NYU Langone Health, New York, New York.; Poage W; Prostate Conditions Education Council, Centennial, Colorado.; Rettig MB; Department of Medicine, Division of Hematology-Oncology, VA Greater Los Angeles, Los Angeles, California.; Departments of Medicine and Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Sartor O; Tulane Cancer Center, New Orleans, Louisiana.; Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Sieber P; Keystone Urology Specialists, Lancaster, Pennsylvania.; Small E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, California.; Yu EY; Department of Medicine, Division of Hematology & Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington.; Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.; Koo PJ; Banner MD Anderson Cancer Center, Phoenix, Arizona.

Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9918591887306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2771-554X (Electronic) Linking ISSN: 2771554X NLM ISO Abbreviation: JU Open Plus Subsets: PubMed not MEDLINE

Loriot Y; Medical Oncology Department, Institut de Cancérologie Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: Yohann.LORIOT@gustaveroussy.fr.; Petrylak DP; Genitourinary Oncology, Yale School of Medicine, New Haven.; Rezazadeh Kalebasty A; School of Medicine, University of California Irvine, Irvine, USA.; Fléchon A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Jain RK; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa.; Gupta S; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, Salt Lake City.; Bupathi M; Medical Oncology, Rocky Mountain Cancer Centers, Littleton, USA.; Beuzeboc P; Oncology and Supportive Care Department, Hôpital Foch, Suresnes, France.; Palmbos P; Urologic Oncology Clinic, Rogel Cancer Center, University of Michigan, Ann Arbor.; Balar AV; Genitourinary Oncology Department, New York University Langone Medical Center, New York.; Kyriakopoulos CE; Division of Hematology, Oncology and Palliative Care, University of Wisconsin-Madison, Madison, USA.; Pouessel D; Department of Medical Oncology and Clinical Research Unit, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse (IUCT-Oncopôle), Toulouse, France.; Sternberg CN; Department of Genitourinary Oncology, Weill Cornell Medical College of Cornell University, New York.; Tonelli J; Clinical Development - Oncology, Gilead Sciences, Inc., Parsippany.; Sierecki M; Clinical Development - Oncology, Gilead Sciences, Inc., Parsippany.; Zhou H; Department of Biometrics, Gilead Sciences, Inc., Foster City.; Grivas P; Department of Medicine, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.; Barthélémy P; Medical Oncology Department, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Tagawa ST; Department of Genitourinary Oncology, Weill Cornell Medical College of Cornell University, New York.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Hoimes CJ; Duke Cancer Institute; Duke University, Durham, NC, USA.; Flaig TW; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.; Milowsky MI; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Friedlander TW; University of California San Francisco Medical Center, San Francisco, CA, USA.; Bilen MA; Winship Cancer Institute of Emory University, Hematology & Medical Oncology, Atlanta, GA, USA.; Gupta S; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.; Srinivas S; Stanford University Medical Center, Stanford, CA, USA.; Merchan JR; University of Miami, Medical Oncology, Miami, FL, USA.; McKay RR; University of California San Diego Moores Cancer Center, San Diego, CA, USA.; Petrylak DP; Yale Comprehensive Cancer Center, New Haven, CT, USA.; Sasse C; Astellas Pharma Global Development, Northbrook, IL, USA.; Moreno BH; Merck & Co., Inc., Rahway, NJ, USA.; Yu Y; Seagen Inc., Bothell, WA, USA.; Carret AS; Seagen Inc., Bothell, WA, USA.; Rosenberg JE; Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY, USA.

Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Sridhar SS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: Srikala.Sridhar@uhn.ca.; Powles T; Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St Bartholomew's Hospital, London, UK.; Climent Durán MÁ; Department of Medical Oncology, Instituto Valenciano de Oncología, València, Spain.; Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; Thiery-Vuillemin A; Department of Medical Oncology, University Hospital Jean Minjoz, Besançon Cedex, France.; Valderrama BP; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Ullén A; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden; Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden.; Tsuchiya N; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.; Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, VA, USA.; Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.; Petrylak DP; Yale Cancer Center, New Haven, CT, USA.; Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Wang J; Pfizer, Cambridge, MA, USA.; Laliberte RJ; Pfizer, Cambridge, MA, USA.; di Pietro A; Pfizer srl, Milano, Italy.; Costa N; Pfizer, Porto Salvo, Portugal.; Grivas P; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Sternberg CN; Hematology/Oncology, Meyer Cancer Center, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Loriot Y; Gustave Roussy, Department of Cancer Medicine, INSERMU981, Université Paris-Saclay, Villejuif, France.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Petrylak DP; Yale School of Medicine, New Haven, Connecticut.; Eigl BJ; BC Cancer, Vancouver, British Columbia, Canada.; George S; Roswell Park Cancer Institute, Buffalo, New York.; Heath EI; Karmanos Cancer Institute, Detroit, Michigan.; Hotte SJ; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.; Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee.; Nabell LM; O'Neal Comprehensive Cancer Center, Birmingham, Alabama.; Picus J; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.; Cheng SY; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Appleman LJ; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Sonpavde GP; Advent Health Cancer Institute, Orlando, Florida.; University of Central Florida, Orlando, Florida.; Morgans AK; Dana-Farber Cancer Institute, Boston, Massachusetts.; Pourhosseini P; Seagen, Woodinville, Washington.; Wu R; Astellas Pharma Global Development, Inc., Northbrook, Illinois.; Standley L; Astellas Pharma Global Development, Inc., Northbrook, Illinois.; Croitoru R; Astellas Pharma Global Development, Inc., Northbrook, Illinois.; Yu EY; Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, Washington.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE